ClinVar Miner

Submissions for variant NM_000033.4(ABCD1):c.454C>T (p.Arg152Cys)

dbSNP: rs1569540693
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000700171 SCV000828916 pathogenic Adrenoleukodystrophy 2018-06-13 criteria provided, single submitter clinical testing This sequence change replaces arginine with cysteine at codon 152 of the ABCD1 protein (p.Arg152Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in several individuals affected with adrenoleukodystrophy (PMID: 7581394, 8651290, 14586615, Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Variants that disrupt the p.Arg152 amino acid residue in ABCD1 have been observed in affected individuals (PMID: 10737980, 7825602, 7581394, 8651290, 14586615). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.
Athena Diagnostics RCV001288421 SCV001475504 likely pathogenic not provided 2020-03-03 criteria provided, single submitter clinical testing Not found in the total gnomAD dataset, and the data is high quality. Predicted to have a damaging effect on the protein. Found in multiple individuals with expected phenotype for this gene.
Revvity Omics, Revvity RCV001288421 SCV002023951 likely pathogenic not provided 2021-03-09 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000700171 SCV002045804 likely pathogenic Adrenoleukodystrophy 2021-11-07 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.